Johnson & Johnson Vaccine Deliveries To Drop Due To Manufacturing Issues

Image of a vaccine shot

There’s going to be a big dip in Johnson & Johnson vaccine deliveries due to woeful failures at the contracted manufacturing plant in Maryland.

From the New York Times:

Johnson & Johnson will allocate 86 percent fewer doses across the United States next week than are currently being allocated, according to data provided by the Centers for Disease Control and Prevention, dealing a setback to a national vaccination campaign that has just found its footing.

The distribution of the drug, a single-shot vaccine, has been inconsistent since Johnson & Johnson delivered its first batch at the beginning of March, sending 2.8 million doses across the country before dipping below 400,000 in the following weeks.

Last month, Johnson & Johnson was forced to jettison up to 15 million doses manufactured at the factory because the batch had been contaminated with a virus used in the production of AstraZeneca’s vaccine, which is also manufactured there.

The Johnson & Johnson shot has been popular for it’s easier to store “one-and-done” single dose.

J & J had previously promised to deliver 24 million new doses by the end of April.

Read the full article here.